Document Detail

Apoptotic effect of CKD-602 (Camtobell) on oral squamous cell carcinoma cell lines.
MedLine Citation:
PMID:  18715816     Owner:  NLM     Status:  MEDLINE    
The purposes of this study were to measure the cytotoxic effect of CKD-602 on oral squamous cell carcinoma (OSCC) cell lines, to evaluate the apoptotic aspect of dead cells, and to identify the signaling molecules involved in apoptosis. The human OSCC cell lines A253, HSC-3 and KB were treated with CKD-602. The apoptotic proportion of the cells was analyzed using flow cytometry. The expression of Bax, Bcl-2, and p53 were detected by western blotting analysis. CKD-602 showed excellent cytotoxicity to the OSCC cell lines. Most cell death was attributed to apoptosis rather than necrosis. CKD-602 induced the down-regulation of Bcl-2 in A253 and HSC-3 cells, and p53 was expressed in the KB cell line after treatment with CKD-602.
Yong-Ju Ok; Hoon Myoung; Young-Kyun Kim; Jong-Ho Lee; Myung-Jin Kim; Pil-Young Yun
Related Documents :
18363966 - Trps1 plays a pivotal role downstream of gdf5 signaling in promoting chondrogenesis and...
16724266 - C-myc downregulation: a critical molecular event in resveratrol-induced cell cycle arre...
19507186 - Radiosensitization of ht-29 cells and xenografts by the nitric oxide donor detanonoate.
16879316 - Melatonin protects against hydrogen peroxide-induced cell death signaling in sh-sy5y cu...
23388496 - Features of autophagic cell death in plasmodium liver-stage parasites.
25476796 - Preclinical biosafety evaluation of cell-based therapies: emerging global paradigms.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2008-08-19
Journal Detail:
Title:  Oral oncology     Volume:  45     ISSN:  1879-0593     ISO Abbreviation:  Oral Oncol.     Publication Date:  2009 Mar 
Date Detail:
Created Date:  2009-02-23     Completed Date:  2010-02-09     Revised Date:  2014-07-31    
Medline Journal Info:
Nlm Unique ID:  9709118     Medline TA:  Oral Oncol     Country:  England    
Other Details:
Languages:  eng     Pagination:  266-72     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Antineoplastic Agents, Phytogenic / pharmacology*
Apoptosis / drug effects*
Camptothecin / analogs & derivatives*,  pharmacology
Carcinoma, Squamous Cell / drug therapy*,  genetics,  metabolism
Cell Line, Tumor
Mouth Mucosa
Mouth Neoplasms / drug therapy*,  genetics,  metabolism
Peptide Fragments
Proto-Oncogene Proteins c-bcl-2 / metabolism
Submandibular Gland Neoplasms / drug therapy,  genetics,  metabolism
Tongue Neoplasms / drug therapy,  genetics,  metabolism
Topoisomerase I Inhibitors*
Tumor Suppressor Protein p53 / biosynthesis
bcl-2-Associated X Protein / metabolism
Reg. No./Substance:
0/Antineoplastic Agents, Phytogenic; 0/Peptide Fragments; 0/Proto-Oncogene Proteins c-bcl-2; 0/Topoisomerase I Inhibitors; 0/Tumor Suppressor Protein p53; 0/bcl-2-Associated X Protein; 0/p53 protein (325-355), human; 27Z82M2G1N/belotecan; XT3Z54Z28A/Camptothecin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Detection of LINE-1s hypomethylation in oral rinses of oral squamous cell carcinoma patients.
Next Document:  beta- and gamma-catenin expression in oral dysplasia.